M2 muscarinic acetylcholine receptors regulate long-term potentiation at hippocampal CA3 pyramidal cell synapses in an input-specific fashion

J Neurophysiol. 2012 Jul;108(1):91-100. doi: 10.1152/jn.00740.2011. Epub 2012 Apr 4.

Abstract

Muscarinic receptors have long been known as crucial players in hippocampus-dependent learning and memory, but our understanding of the cellular underpinnings and the receptor subtypes involved lags well behind. This holds in particular for the hippocampal CA3 region, where the mechanisms of synaptic plasticity depend on the type of afferent input. Williams and Johnston (Williams S, Johnston D. Science 242: 84-87, 1988; Williams S, Johnston D. J Neurophysiol 64: 1089-1097, 1990) demonstrated muscarinic depression of mossy fiber (MF) long-term potentiation (LTP) through a presynaptic site of action and Maeda et al. (Maeda T, Kaneko S, Satoh M. Brain Res 619: 324-330, 1993) proposed a bidirectional modulation of MF LTP by muscarinic receptor subtypes. Since then, this issue, as well as muscarinic regulation of plasticity at associational/commissural (A/C) fiber-CA3 synapses has remained largely neglected, not least because of the lack of highly selective ligands for the different muscarinic receptor subtypes. In the present study, we performed field potential and whole cell recordings from the hippocampal CA3 region of M(2) receptor knockout mice to determine the role of M(2) receptors in short-term and long-term plasticity at A/C and MF inputs to CA3 pyramidal cells. At the A/C synapse, M(2) receptors promoted short-term facilitation and LTP. Unexpectedly, M(2) receptors mediated the opposite effect on LTP at the MF synapse, which was significantly reduced, most likely involving a depressant effect of M(2) receptors on adenylyl cyclase activity in MF terminals. Our data demonstrate that cholinergic projections recruit M(2) receptors to redistribute the gain of LTP in CA3 pyramidal cells in an input-specific manner.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anthracenes / pharmacology
  • Anticonvulsants / pharmacology
  • Biophysical Phenomena / drug effects
  • Biophysical Phenomena / genetics
  • Bungarotoxins / pharmacology
  • CA3 Region, Hippocampal / cytology*
  • Colforsin / pharmacology
  • Cyclopropanes / pharmacology
  • Electric Stimulation
  • Enzyme Inhibitors / pharmacology
  • Excitatory Postsynaptic Potentials / drug effects
  • Excitatory Postsynaptic Potentials / genetics
  • GABA Antagonists / pharmacology
  • Gallamine Triethiodide / pharmacology
  • Glycine / analogs & derivatives
  • Glycine / pharmacology
  • In Vitro Techniques
  • Long-Term Potentiation / drug effects
  • Long-Term Potentiation / genetics
  • Long-Term Potentiation / physiology*
  • Mice
  • Mice, Knockout
  • Nerve Net / physiology
  • Nicotinic Antagonists / pharmacology
  • Patch-Clamp Techniques
  • Phosphinic Acids / pharmacology
  • Propanolamines / pharmacology
  • Pyramidal Cells / physiology*
  • Receptor, Muscarinic M2 / deficiency
  • Receptor, Muscarinic M2 / metabolism*
  • Synapses / drug effects
  • Synapses / genetics
  • Synapses / physiology*
  • Time Factors

Substances

  • 2,3-didecyloxyanthracene
  • Anthracenes
  • Anticonvulsants
  • Bungarotoxins
  • Cyclopropanes
  • Enzyme Inhibitors
  • GABA Antagonists
  • Nicotinic Antagonists
  • Phosphinic Acids
  • Propanolamines
  • Receptor, Muscarinic M2
  • 2-(2,3-dicarboxycyclopropyl)glycine
  • CGP 55845A
  • Colforsin
  • Gallamine Triethiodide
  • Glycine